Apotex Names Jeremy B. Desai as CEO

From DCAT Value Chain Insights (VCI)

By People On The Move posted 08-29-2014 12:39

Apotex has named Jeremy B. Desai as president and CEO and Jack Kay, the former CEO of Apotex to the position of vice chairman of the board. Both assumed their posts, effective August 1, 2014.

Born in London, England, Dr. Desai gained a pharmacy degree in 1981, a PhD in 1985, and an MBA in 1993. He has spent close to 30 years in progressively senior positions in the pharmaceutical industry. He has been at Apotex for the last 11 years in different roles, including executive vice president and global head of R&D and most recently as president and chief operating officer.

Source: Apotex

Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription